Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2009 Apr;25(2):113-9.
doi: 10.1089/jop.2008.0098.

Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells

Affiliations
Comparative Study

Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells

Seth P Epstein et al. J Ocul Pharmacol Ther. 2009 Apr.

Abstract

Purpose: Nearly all eye drops contain preservatives to decrease contamination. Nonpreservatives such as disodium-ethylene diamine tetra-acetate (EDTA) and phosphate-buffered saline are also regularly added as buffering agents. These components can add to the toxicity of eye drops and cause ocular surface disease. To evaluate the potential toxicity of these common components and their comparative effects on the ocular surface, a tissue culture model utilizing immortalized corneal and conjunctival epithelial cells was utilized.

Methods: Immortalized human conjunctival and corneal epithelial cells were grown. At confluency, medium was replaced with 100 microL of varying concentrations of preservatives: benzalkonium chloride (BAK), methyl paraben (MP), sodium perborate (SP), chlorobutanol (Cbl), and stabilized thimerosal (Thi); varying concentrations of buffer: EDTA; media (viable control); and formalin (dead control). After 1 h, solutions were replaced with 150 microL of MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazonium bromide). After 4 h, solutions decanted, 100 microL of acid isopropanol added, and the optical density determined at 572 nm to evaluate cell viability.

Results: Conjunctival and corneal cell toxicity was seen with all preservatives. Depending upon concentration, BAK exhibited from 56% to 89% toxicity. In comparison, Cbl exhibited from 50% to 86%, MP from 30% to 76%, SP from 23% to 59%, and Thi from 70% to 95%. EDTA with minimal toxicity (from 6% to 59%) was indistinguishable from SP.

Conclusions: Generally, the order of decreasing toxicity at the most commonly used concentrations: Thi (0.0025%) > BAK (0.025%) > Cbl (0.25%) > MP (0.01%) > SP (0.0025%) approximately EDTA (0.01%). Even at low concentration, these agents will cause some degree of ocular tissue damage.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Graphic representation of overall relative toxicities of human corneal (gray bars; 10.014 pRSV-T) and conjunctival epithelial cells (black; Wong–Kilbourne derivative of conjunctiva, clone 1-5c-4) after being put into contact with the most commonly used concentration of each of the experimental testing solutions (10% formalin [dead control], stabilized thimerosal [Thi: 0.0025%], benzalkonium chloride [BAK: 0.025%], chlorobutanol [Cbl: 0.25%], methyl paraben [MP: 0.01%], sodium perborate [SP: 0.0025%], disodium-ethylene diamine tetra-acetate [EDTA: 0.01%], and media alone [total viable control]) for 1 h.

Similar articles

Cited by

References

    1. Noecker R. Effects of common ophthalmic preservatives on ocular health. Adv.Ther. 2001;18:205–215. - PubMed
    1. Spickett C. Studies of Cellular Responses to Purite and Other Preservatives. Strathclyde, UK: University of Strathclyde; 2001.
    1. Asbell P.A. Fifth 5th International Symposium on Ocular Pharmacology and Therapeutics (ISOPT) Monte Carlo: Monaco; Mar 11–14, 2004. Tear Substitutes: Past, Present and Future.
    1. Noecker R. Herrygers L. Anwaruddin R. Corneal and conjunctival changes caused by commonly used glaucoma medications. Cornea. 2004;23:490–496. - PubMed
    1. Noecker R. Protecting the ocular surface in glaucoma and keratoconjunctivitis sicca. A Supplement to Refractive Eyecare® for Ophthalmologists. 2004;8:1–10.

Publication types

LinkOut - more resources